Docetaxel Trihydrate
| CAS No. | 148408-66-6 |
|---|---|
| MDL No. | N/A |
| MF | C43H59NO17 |
| MW | 861.90 |
| InChI Key | XCDIRYDKECHIPE-QHEQPUDQSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Docetaxel trihydrate is the trihydrate form of docetaxel. It is used in the treatment of breast, ovarian, and non-small cell lung cancer, and in combination with prednisone or prednisolone for hormone-refractory metastatic prostate cancer. It functions as an antineoplastic agent and is a hydrate and secondary alpha-hydroxy ketone containing a member of docetaxel anhydrous.
| CAS No. | 148408-66-6 |
|---|---|
| Product Name | Docetaxel Trihydrate |
| Heavy Atom Count | 61 | Rotatable Bond Count | 8 |
| Atom Stereo Count | 11 | Bond Stereo Count | 0 |
| HBA | 14 | HBD | 5 |
| TPSA | 318.950 Ų | Charge | 0 |
| Exact Mass | 861.37830 | Complexity | 1982.16 |
| pKa | 7.130 | XLogP | 0.786 |
